Christiana Care Breast Center nurse awarded 2010 Pearl Moore Making a Difference Award from ONS

NewsGuard 100/100 Score

Darcy Burbage, RN, MSN, AOCN®, CBCN®, clinical nurse specialist at the Christiana Care Breast Center at the Helen F. Graham Cancer Center, is the 2010 recipient of the Pearl Moore Making a Difference Award from the Oncology Nursing Society (ONS).

ONS is a professional organization of 37,000 registered nurses and other health care professionals committed to excellence in oncology nursing.

The award recognizes Burbage's significant contributions to the oncology nursing profession at the local and regional levels. She is recognized for her many performance improvement projects that have enhanced the quality of care of patients with breast cancer and for being a well-respected leader and mentor.

"To have been selected to receive this award named after a pioneer in the field of oncology nursing is an honor," says Burbage. "It is a testament to the many talented nurses, physicians, managers and support staff who have mentored me throughout my career as well as the patients who allowed me into their lives."

The award is named for Pearl Moore, a charter member of ONS who served as CEO for more than 25 years.

Burbage will receive the award on May 13 in San Diego, CA.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge